Previous Article | Next Article 
Journal of Clinical Microbiology, April 1999, p. 1004-1007, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Comparison of Isolation Media for Recovery of Burkholderia
cepacia Complex from Respiratory Secretions of Patients with
Cystic Fibrosis
Deborah
Henry,1
Maureen
Campbell,1
Colleen
McGimpsey,2
Alison
Clarke,2
Laurie
Louden,3
Jane L.
Burns,3,4
Martha H.
Roe,5
Peter
Vandamme,6 and
David
Speert1,*
Division of Infectious and Immunological
Diseases, Department of Pediatrics, University of British
Columbia,1 and Department of
Microbiology, Saint Paul's Hospital,2
Vancouver, British Columbia, Canada; Department of Pediatrics,
Children's Hospital and Regional Medical
Center,3 and Division of Infectious
Disease, University of Washington School of
Medicine,4 Seattle, Washington;
Department of Pathology, The Children's Hospital, Denver,
Colorado5; and Laboratory of
Microbiology, Universiteit Gent, Ghent, Belgium6
Received 5 October 1998/Returned for modification 23 November
1998/Accepted 13 January 1999
Burkholderia cepacia selective agar (BCSA) has
previously been devised for isolation of B. cepacia from
respiratory secretions of patients with cystic fibrosis and tested
under research laboratory conditions. Here we describe a study in which
BCSA, oxidation-fermentation polymyxin bacitracin lactose agar (OFPBL),
and Pseudomonas cepacia agar (PCA) were compared in routine
culture procedures for the ability to grow B. cepacia and
inhibit other organisms. Three hundred twenty-eight specimens from 209 patients at two pediatric centers and 328 specimens from 109 adults
were tested. Plates were inoculated, incubated, and read for quality
and quantity of growth at 24, 48, and 72 h. Five (1.5%) specimens
from 4 (1.9%) children and 75 (22.9%) specimens from 16 (14.7%)
adults grew B. cepacia complex. At 24, 48, and 72 h,
BCSA achieved 43, 93, and 100% detection, respectively; OFPBL achieved
26, 84, and 96%, respectively; and PCA achieved 33, 74, and 84%
detection, respectively. Quality was assessed as pinpoint or good
growth. At 24 h, most cultures growing B. cepacia
complex had pinpoint colonies. By 48 and 72 h, 48 and 69% of
B. cepacia complex cultures, respectively, had good growth
on BCSA, while on OFPBL 19 and 30%, respectively, had good growth and
on PCA 11 and 18%, respectively, had good growth. BCSA was superior to
OFPBL and PCA in suppressing organisms other than B. cepacia complex; 40 non-B. cepacia complex organisms were isolated from BCSA, 263 were isolated from OFPBL, and 116 were
isolated from PCA. We conclude that BCSA is superior to OFPBL and PCA
in its ability to support the growth of B. cepacia complex and to suppress other respiratory organisms.
*
Corresponding author. Mailing address: BC Research
Institute of Women's and Children's Health, Room 375, 950 West 28th
Ave., Vancouver, BC V5Z 4H4, Canada. Phone: (604) 875-2438. Fax: (604) 875-2226. E-mail: speert{at}unixg.ubc.ca.
Journal of Clinical Microbiology, April 1999, p. 1004-1007, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Glass, M. B., Beesley, C. A., Wilkins, P. P., Hoffmaster, A. R.
(2009). Comparison of Four Selective Media for the Isolation of Burkholderia mallei and Burkholderia pseudomallei. Am J Trop Med Hyg
80: 1023-1028
[Abstract]
[Full Text]
-
Segonds, C., Clavel-Batut, P., Thouverez, M., Grenet, D., Le Coustumier, A., Plesiat, P., Chabanon, G.
(2009). Microbiological and Epidemiological Features of Clinical Respiratory Isolates of Burkholderia gladioli. J. Clin. Microbiol.
47: 1510-1516
[Abstract]
[Full Text]
-
Kooi, C., Subsin, B., Chen, R., Pohorelic, B., Sokol, P. A.
(2006). Burkholderia cenocepacia ZmpB Is a Broad-Specificity Zinc Metalloprotease Involved in Virulence. Infect. Immun.
74: 4083-4093
[Abstract]
[Full Text]
-
Kooi, C., Corbett, C. R., Sokol, P. A.
(2005). Functional Analysis of the Burkholderia cenocepacia ZmpA Metalloprotease. J. Bacteriol.
187: 4421-4429
[Abstract]
[Full Text]
-
Daxboeck, F., Stadler, M., Assadian, O., Marko, E., Hirschl, A. M, Koller, W.
(2005). Characterization of clinically isolated Ralstonia mannitolilytica strains using random amplification of polymorphic DNA (RAPD) typing and antimicrobial sensitivity, and comparison of the classification efficacy of phenotypic and genotypic assays. J Med Microbiol
54: 55-61
[Abstract]
[Full Text]
-
De Boeck, K., Malfroot, A., Van Schil, L., Lebecque, P., Knoop, C., Govan, J.R.W., Doherty, C., Laevens, S., Vandamme, P.
(2004). Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients. Eur Respir J
23: 851-856
[Abstract]
[Full Text]
-
Gibson, R. L., Burns, J. L., Ramsey, B. W.
(2003). Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
168: 918-951
[Abstract]
[Full Text]
-
Miller, M. B., Gilligan, P. H.
(2003). Laboratory Aspects of Management of Chronic Pulmonary Infections in Patients with Cystic Fibrosis. J. Clin. Microbiol.
41: 4009-4015
[Full Text]
-
Detsika, M. G., Corkill, J. E., Magalhaes, M., Glendinning, K. J., Hart, C. A., Winstanley, C.
(2003). Molecular Typing of, and Distribution of Genetic Markers among, Burkholderia cepacia Complex Isolates from Brazil. J. Clin. Microbiol.
41: 4148-4153
[Abstract]
[Full Text]
-
Brisse, S., Stefani, S., Verhoef, J., Van Belkum, A., Vandamme, P., Goessens, W.
(2002). Comparative Evaluation of the BD Phoenix and VITEK 2 Automated Instruments for Identification of Isolates of the Burkholderia cepacia Complex. J. Clin. Microbiol.
40: 1743-1748
[Abstract]
[Full Text]
-
McDowell, A., Mahenthiralingam, E., Moore, J. E., Dunbar, K. E. A., Webb, A. K., Dodd, M. E., Martin, S. L., Millar, B. C., Scott, C. J., Crowe, M., Elborn, J. S.
(2001). PCR-Based Detection and Identification of Burkholderiacepacia Complex Pathogens in Sputum from Cystic Fibrosis Patients. J. Clin. Microbiol.
39: 4247-4255
[Abstract]
[Full Text]
-
Saiman, L., Chen, Y., Tabibi, S., San Gabriel, P., Zhou, J., Liu, Z., Lai, L., Whittier, S.
(2001). Identification and Antimicrobial Susceptibility of Alcaligenes xylosoxidans Isolated from Patients with Cystic Fibrosis. J. Clin. Microbiol.
39: 3942-3945
[Abstract]
[Full Text]
-
Coenye, T., Vandamme, P., Govan, J. R. W., LiPuma, J. J.
(2001). Taxonomy and Identification of the Burkholderia cepacia Complex. J. Clin. Microbiol.
39: 3427-3436
[Full Text]
-
Wright, R M, Moore, J E, Shaw, A, Dunbar, K, Dodd, M, Webb, K, Redmond, A O B, Crowe, M, Murphy, P G, Peacock, S, Elborn, J S
(2001). Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis. J. Clin. Pathol.
54: 803-805
[Abstract]
[Full Text]
-
McMenamin, J. D., Zaccone, T. M., Coenye, T., Vandamme, P., LiPuma, J. J.
(2000). Misidentification of Burkholderia cepacia in US Cystic Fibrosis Treatment Centers : An Analysis of 1,051 Recent Sputum Isolates. Chest
117: 1661-1665
[Abstract]
[Full Text]
-
Brisse, S., Verduin, C. M., Milatovic, D., Fluit, A., Verhoef, J., Laevens, S., Vandamme, P., Tümmler, B., Verbrugh, H. A., van Belkum, A.
(2000). Distinguishing Species of the Burkholderia cepacia Complex and Burkholderia gladioli by Automated Ribotyping. J. Clin. Microbiol.
38: 1876-1884
[Abstract]
[Full Text]